Trial Profile

A Phase I Study of Ansofaxine Hydrochloride Extended Release Tablets (LY03005) for the Treatment of Depression in Japan

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 04 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Toludesvenlafaxine (Primary)
Indications Major depressive disorder
Focus Therapeutic Use
Sponsors Luye Pharma Group

Most Recent Events

29 Aug 2019 Status changed from planning to recruiting, according to a Luye Pharma Group media release.
28 Aug 2019 New trial record
22 Aug 2019 According to a Luye Pharma Group media release, the company has submitted clinical trials application to start clinical trial soon.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com